Bristol-Myers Squibb | BMY - Vermögenswerte





Vermögenswerte Veränderung Datum
AbbVie USD 147.68B 12.57B 2026-09
Abbott USD 108.25B 968M 2026-09
ALKERMES USD 4.44B 42.4M 2026-09
Amgen USD 96.05B 409M 2026-09
AstraZeneca USD 119.92B 4.09B 2026-09
Biogen USD 32.05B 32.5M 2026-09
Bristol-Myers Squibb USD 88.77B 1.14B 2026-09
Coherus Biosciences USD 191.18M 74.84M 2026-06
Drreddys Laboratories INR 574.48B 4.86B 2026-09
Eli Lilly USD 148.07B 5.79B 2026-09
Gilead Sciences USD 51.41B 2.05B 2026-09
GlaxoSmithKline GBP 71.7B 9.96B 2026-09
J&J USD 197.42B 3.64B 2026-09
Medtronic USD 93.31B 278M 2026-06
Merck USD 132.77B 2.97B 2026-09
Novartis USD 117.15B 4.88B 2026-09
Novo Nordisk DKK 594.94B 35.72B 2026-06
Perrigo USD 7.48B 124.6M 2026-09
Pfizer USD 204.54B 3.41B 2026-09
Phibro Animal Health USD 1.51B 13.48M 2026-09
Prestige Brands USD 4.72B 153.09M 2026-09
Regeneron Pharmaceuticals USD 44.41B 2.67B 2026-09
Roche Holding CHF 98.2B 2.5B 2026-06
Sanofi EUR 130.29B 1.23B 2026-09
Sanofi EUR 129.06B 1.04B 2026-06
United Therapeutics USD 7.03B 186M 2026-09
Zoetis USD 15.09B 11M 2026-09